Curis, Inc.
516 articles about Curis, Inc.
-
Curis, Inc. to Present at 19th Annual Oppenheimer Healthcare Conference
10/28/2008
-
Curis, Inc. Reports Third Quarter 2008 Financial Results
10/28/2008
-
Curis, Inc. to Present at 7th Annual Biotechnology Industry Organization (BIO) Investor Forum Conference
10/23/2008
-
Curis, Inc. Announces Preclinical Efficacy Data for CUDC-305 at EORTC-NCI-AACR Symposium
10/23/2008
-
Curis, Inc. to Release Third Quarter 2008 Financial Results and Hold Conference Call on October 28, 2008
10/21/2008
-
Curis, Inc. to Present at First Annual Boston Biotech R&D Conference
10/16/2008
-
Curis, Inc. To Present At Maxim Group Growth Conference 2008
9/30/2008
-
Curis, Inc. to Present atMerriman Curhan Ford 5th Annual Investor Summit 2008
9/8/2008
-
Curis, Inc. Announces GDC-0449 Phase II Ovarian Cancer Trial Design
8/28/2008
-
Curis, Inc. Announces Nature Publication Elucidating a Paracrine Mechanism of Action in Hedgehog-Expressing Tumors
8/27/2008
-
Curis, Inc. Announces Dosing of First Patient in Phase I Clinical Trial of CUDC-101
8/26/2008
-
Curis, Inc. to Present at Noble Financial Capital Markets 5th Annual Equity Conference
8/11/2008
-
Curis, Inc. Reports Second Quarter 2008 Financial Results
7/30/2008
-
Curis, Inc. to Release Second Quarter 2008 Financial Results and Hold Conference Call on July 30, 2008
7/23/2008
-
Curis, Inc. Selects Hsp90 Inhibitor CUDC-305 as Development Candidate from Targeted Cancer Drug Development Platform
7/21/2008
-
Curis, Inc. Announces GDC-0449 Phase I Clinical Data Presented at American Society of Clinical Oncology Annual Meeting 2008
6/2/2008
-
Curis, Inc. to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
5/12/2008
-
Curis, Inc. Reports First Quarter 2008 Financial Results
4/30/2008
-
Curis, Inc. to Present at Deutsche Bank 33rd Annual Healthcare Conference
4/29/2008
-
Curis, Inc. to Release First Quarter 2008 Financial Results and Hold Conference Call on April 30, 2008
4/23/2008